Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 6, 2026

Jul. 6, 2026

Five Reputable Wooden Swing Sets Manufacturers China 2026: Delivering Safe & Durable Outdoor Play Equipment

Indeterminate EIN Presswire

Jul. 6, 2026

The Ohio Academy of Science announces 2026 National Youth Science Camp delegates

Indeterminate EIN Presswire

Jul. 6, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Cal-Maine Foods Schedules Fourth Quarter and Fiscal Year 2026 Earnings Release, Conference Call and Webcast

Indeterminate GlobeNewswire

Jul. 6, 2026

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Indeterminate GlobeNewswire

Jul. 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Indeterminate GlobeNewswire

Jul. 6, 2026

Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker

Indeterminate GlobeNewswire

Jul. 6, 2026

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire

Jul. 6, 2026

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Indeterminate GlobeNewswire

Jul. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine

Indeterminate GlobeNewswire

Jul. 6, 2026

Potato Protein Market to Reach US$461.2 Mn by 2033 Driven by Plant-Based Nutrition

Indeterminate EIN Presswire